Chang‐Ki Min

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 380 citations

Medicine, Pharmacology, Pharmacotherapy +12

Microenvironmental Remodeling as a Parameter and Prognostic Factor of Heterogeneous Leukemogenesis in Acute Myelogenous Leukemia

Jin‐A Kim, Jae‐Seung Shim, Ga Young Lee et al. · Cancer Research · 2015 · 152 citations

Medicine, Hematology, Oncology +17

Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

Thomas G. Martin, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · Blood Cancer Journal · 2023 · 95 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Successful Prevention of Acute Graft-versus-Host Disease Using Low-Dose Antithymocyte Globulin after Mismatched, Unrelated, Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia

Hee‐Je Kim, Woo-Sung Min, Byung‐Sik Cho et al. · Biology of Blood and Marrow Transplantation · 2009 · 76 citations · Full text

Medicine, Hematology, Immunology +14

Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer: association with histopathological features and subtypes

Yun Ju Kim, Kyounglan Ko, Daehong Kim et al. · British Journal of Radiology · 2016 · 60 citations · Full text

Medicine, Oncology, Radiology +17